Related Experiment Video
Updated: Jun 24, 2026

05:33
A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep
Carole Pomier1, Maria Teresa Sanchez Alcaraz, Christophe Debacq
1CNRS FRE-3011-Université Lyon I, Oncovirologie et Biothérapies, Centre Léon Bérard, Lyon, France. ptepoms@yahoo.fr
Retrovirology
|April 7, 2009
Summary
Bovine leukemia virus (BLV) replication levels determine deltaretrovirus-induced cancer development in sheep. Higher viral replication correlates with increased malignancy risk and faster disease progression.
Area of Science:
- Veterinary Medicine
- Oncology
- Virology
Background:
- Retrovirus infections cause tumors with variable latency periods.
- Deltaretroviruses, like BLV, typically induce hematological malignancies in a small fraction of infected individuals after long latency.
Purpose of the Study:
- To investigate the factors influencing deltaretrovirus-induced leukemogenesis.
- To determine the role of bovine leukemia virus (BLV) replication levels in malignancy development in sheep.
Main Methods:
- Experimental infection of sheep with either leukemogenic or attenuated BLV molecular clones.
- Prospective monitoring of viral replication, reverse transcription (RT) levels, infected cell clonal expansion, and circulating proviruses for 8 months.
Main Results:
- Malignancy development in BLV-infected sheep was directly dependent on the level of BLV replication.
- Leukemogenic BLV clones showed significantly higher RT levels, infected cell expansion, and proviral mutations compared to attenuated clones.
- Both virus types induced parallel fluctuations in host lymphoid cells, viral loads, and infected cell proliferation, indicating quantitative differences.
Conclusions:
- Deltaretrovirus-induced leukemogenesis in sheep is a multi-step process.
- The amount of horizontally and vertically transmitted BLV is critical for disease progression over time.

